Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

CiproPAL (Ciprofloxacin Prophylaxis in Acute Leukaemia): A Randomised Trial to Assess the Use of Ciprofloxacin Prophylaxis to Prevent Bacterial Infection in Children Treated on the Induction Phase of the ALLTogether-1 Treatment Protocol

NCT04678869 is registered in ClinicalTrials.gov with University College, London as lead sponsor.

NCT NCT04678869
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04678869 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
CiproPAL (Ciprofloxacin Prophylaxis in Acute Leukaemia): A Randomised Trial to Assess the Use of Ciprofloxacin Prophylaxis to Prevent Bacterial Infection in Children Treated on the Induction Phase of the ALLTogether-1 Treatment Protocol
Lead sponsor
University College, London
Phase
Not applicable
Overall status
Active, not recruiting
Start date
June 29, 2022
Completion date
June 1, 2028
Enrollment
313 (actual)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

acute lymphoblastic leukaemia - category